Abstract:BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a hereditary disease caused by pathogenic mutations of G6PD. While most of the pathogenic variants of G6PD have been annotated, hemolysis of unknown etiology but analogous to that in G6PD deficiency persists, implying the existence of undocumented pathogenic variants. In our previous study, we reported four novel G6PD variants in China, for which the pathogenicity remains to be verified.METHODS: The variants were verified by exogenous expression in HEK-293 cells, and their functions were predicted by PolyPhen-2 and SIFT. The CRISPR/Cas9 system was exploited to edit the G6PD c.697G>C variant in HEK-293 cells and K562 cells. The expression of G6PD was detected by quantitative PCR (qPCR) and western blotting. The cell growth capacity was detected by the CCK-8 assay and crystal violet staining. The G6PD enzyme activity was reflected by the G6P/6PG ratio test. The apoptosis of cells was detected by Annexin V-APC/7-AAD staining. The secondary and crystallographic structures were denoted according to the literature and PyMOL software. The G6PD protein was purified from lysis of transformed Escherichia coli (E. coli) cell with Ni-charged Resin Column. The enzymatic activity was detected at different temperatures.RESULTS: The G6PD activity of exogenous G6PD c.697G>C in HEK-293 cells was significantly lower than that of wild type (WT) G6PD, a finding that was consistent with the observation in clinical samples. The functional predictions conducted by different algorithms indicated the damage role of the G6PD c.697G>C variant in its enzymatic activity. We recapitulated the G6PD c.697G>C variant both in HEK-293 cells and K562 cells by adapting the CRISPR/Cas9 strategy. Using distinct cell lines expressing the G6PD c.697G>C variant endogenously, we confirmed the deteriorative role of the G6PD c.697G>C variant in its enzymatic activity. Regarding the secondary and crystallographic structure, we found a mutated amino acid approaching the structural NADP+ binding site. Finally, we demonstrated the c.697G>C variant compromised the thermal stability of G6PD protein.CONCLUSIONS: Our data delineated the pathogenic role of G6PD c.697G>C variant for G6PD deficiency, implying the wide usage of CRISPR/Cas9 for genetic disease research.

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C

Integrative Identification of the Pathogenic Role of a Novel G6PD Missense Mutation C.697g>c

Construction of CRISPR/Cas9-mediated genomic deletion of the CYP2E1 gene in human HEK293FT cell line

Construction of GLRX3-knockout HEK 293 cell line by CRISPR/Cas9 technology

Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.

A simple, rapid, and efficient method for generating multigene-knockout culture cells by the CRISPR/Cas9 system

A refined method to study gene dosage changes in vitro using CRISPR/Cas9

GENE-10. A SIMPLE AND EFFICIENT METHOD FOR GENERATING MULTI-ALLELIC INSERTION-DELETION MUTATIONS AND PRECISE DELETIONS IN PRIMARY HUMAN CELL CULTURES

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.

An Efficient and Precise Method for Generating Knockout Cell Lines Based on CRISPR‐Cas9 System

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

[Construction of a stable TrxR1 knockout HCT-116 cell line using CRISPR/Cas9 gene editing system]

A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures

Screening and efficiency verification of CRISPR-Cas9 single-guide RNA against human tumor suppressor gene p53 and PTEN

Protective Protein/Cathepsin A Loss in Cultured Cells Derived from an Early-Infantile Form of Galactosialidosis Patients Homozygous for the A1184-G Transition (y395c Mutation)

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

3092 – CRISPR OPTIMIZATION TO SCREEN FOR GENES THAT REGULATE FATE SPECIFICATION OF PRIMARY HUMAN HEMATOPOIETIC PROGENITORS

CRISPR/Cas9 Mediated Homology Recombination Insertion Knockout of Human SH2B3 Gene

[Establishment of a stable HEK293T cell line with c.392G&gt;T (p.131G&gt;V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C

Integrative Identification of the Pathogenic Role of a Novel G6PD Missense Mutation C.697g&gt;c

Construction of CRISPR/Cas9-mediated genomic deletion of the CYP2E1 gene in human HEK293FT cell line

Construction of GLRX3-knockout HEK 293 cell line by CRISPR/Cas9 technology

Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.

A simple, rapid, and efficient method for generating multigene-knockout culture cells by the CRISPR/Cas9 system

A refined method to study gene dosage changes in vitro using CRISPR/Cas9

GENE-10. A SIMPLE AND EFFICIENT METHOD FOR GENERATING MULTI-ALLELIC INSERTION-DELETION MUTATIONS AND PRECISE DELETIONS IN PRIMARY HUMAN CELL CULTURES

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.

An Efficient and Precise Method for Generating Knockout Cell Lines Based on CRISPR‐Cas9 System

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

[Construction of a stable TrxR1 knockout HCT-116 cell line using CRISPR/Cas9 gene editing system]

A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures

Screening and efficiency verification of CRISPR-Cas9 single-guide RNA against human tumor suppressor gene p53 and PTEN

Protective Protein/Cathepsin A Loss in Cultured Cells Derived from an Early-Infantile Form of Galactosialidosis Patients Homozygous for the A1184-G Transition (y395c Mutation)

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

3092 – CRISPR OPTIMIZATION TO SCREEN FOR GENES THAT REGULATE FATE SPECIFICATION OF PRIMARY HUMAN HEMATOPOIETIC PROGENITORS

CRISPR/Cas9 Mediated Homology Recombination Insertion Knockout of Human SH2B3 Gene

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

Integrative Identification of the Pathogenic Role of a Novel G6PD Missense Mutation C.697g>c